Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 20
Filter
1.
J Diabetes Res ; 2016: 5842701, 2016.
Article in English | MEDLINE | ID: mdl-26824044

ABSTRACT

As numerous studies put in evidence the increasing incidence of type 1 diabetes (T1D) in children, an early diagnosis is of great importance to define correct treatment and diet. Currently, the identification of classical islet autoantibodies is the primary biomarker for diagnosis in subjects at risk, especially in pediatric patients. Recent studies suggest that detection of antibodies against ZnT8 protein in preclinical phase can predict the development of T1D. We previously demonstrated a significant association of Mycobacterium avium subspecies paratuberculosis (MAP) with T1D in adult Sardinian patients. To enforce this finding, we investigated the presence of antibodies against ZnT8 and proinsulin (PI) with respective homologous epitopes: MAP3865c133-141/ZnT8186-194, MAP3865c125-133/ZnT8178-186, MAP2404c70-85/PI46-61, and MAP1,4αgbp157-173/PI64-80, in 23 children at risk for T1D, formerly involved in the TRIGR study, and 22 healthy controls (HCs). Positivity to anti-MAP and homologous human peptides was detected in 48% of at-risk subjects compared to 5,85% HCs, preceding appearance of islet autoantibodies. Being MAP easily transmitted to humans with infected cow's milk and detected in retail infant formulas, MAP epitopes could be present in extensively hydrolyzed formula and act as antigens stimulating ß-cell autoimmunity.


Subject(s)
Antibodies, Bacterial/blood , Antigens, Bacterial/immunology , Autoantibodies/blood , Cation Transport Proteins/immunology , Diabetes Mellitus, Type 1/blood , Islets of Langerhans/immunology , Mycobacterium avium subsp. paratuberculosis/immunology , Proinsulin/immunology , Age Factors , Antibody Specificity , Biomarkers/blood , Case-Control Studies , Child , Child, Preschool , Cross Reactions , Diabetes Mellitus, Type 1/diagnosis , Diabetes Mellitus, Type 1/immunology , Diabetes Mellitus, Type 1/microbiology , Early Diagnosis , Epitopes , Humans , Infant , Infant, Newborn , Italy , Predictive Value of Tests , Zinc Transporter 8
2.
PLoS One ; 10(7): e0133497, 2015.
Article in English | MEDLINE | ID: mdl-26192189

ABSTRACT

Hashimoto's thyroiditis (HT) is the prevailing organ-specific autoimmune disease in Sardinia, often complicated with other autoimmune disorders, most commonly type 1 diabetes (T1D). While numerous studies describe levels of anty-thyroid antibodies (Abs) in T1D patients, few papers evaluate the status of anti-islet autoimmunity in subjects affected by HT. Previously, we portrayed Mycobacterium avium subspecies paratuberculosis (MAP) as an environmental factor strongly associated with both diseases. In this study, we analyzed plasma of Sardinian HT patients (n=177) and healthy controls (HCs; n=175) for the presence of Abs against proinsulin and MAP-derived homologous epitopes: MAP1,4αgbp157-173/PI64-80 were recognized by 5,08% and 18,64% of HT vs 0,57% and 7,43% of HCs (AUC=0,6 for both; p<0,0003 and 0,002, respectively), whereas the prevalence of Abs against MAP2404c70-85/PI46-61 peptides was higher but not significant in patients when compared to HCs. In women (n=152), Abs against MAP1,4αgbp157-173 were detected in 12,50% of HT vs 2,75% of HCs (AUC=0,63; p<0,0002), while positivity to its human homolog PI64-80 was observed in 16,42% of HT vs 6,42% of HCs (AUC=0,61; p<0,001). In men (n=25), a significant anti-PI46-61 Abs levels were detected in 4% of HT vs none of the HCs (AUC=0,7; p<0,003). Age-related analyses revealed the highest prevalence between 31-40 years old (45,83%) in the total study population and among males (33,33%); in contrast, women had a higher seroreactivity between 51-60 years (42,11%). A further follow-up and determination of anti-islet Abs levels is needed to evaluate the association of immune responses directed against the MAP/PI homologous peptides with progression to overt diabetes in HT subjects.


Subject(s)
Antibodies, Bacterial/immunology , Autoantibodies/immunology , Epitopes/immunology , Hashimoto Disease/immunology , Mycobacterium avium subsp. paratuberculosis/immunology , Proinsulin/immunology , Adult , Age Factors , Antibodies, Bacterial/blood , Autoantibodies/blood , Diabetes Mellitus, Type 1/immunology , Enzyme-Linked Immunosorbent Assay , Female , Hashimoto Disease/blood , Humans , Iodide Peroxidase/immunology , Italy , Male , Middle Aged , Sex Factors , Thyroid Hormones/blood
3.
J Infect Dev Ctries ; 9(6): 631-4, 2015 Jul 04.
Article in English | MEDLINE | ID: mdl-26142673

ABSTRACT

INTRODUCTION: The Helicobacter pylori (HP) reinfection rate seems to be higher in developing countries than in developed ones. An increased seroprevalence of HP has also been reported in patients with type 1 diabetes (T1D) and Hashimoto's thyroiditis (HT). Mycobacterium avium subsp. paratuberculosis (MAP) has been linked to both T1D and HT. Quite a few lines of evidence indicate that autoantibodies against several epitopes belonging to human zinc transporter 8 (ZnT8) cross-recognize the homologous MAP3865c epitopes in both T1D and HT patients. HP may play a role in HT disease, most likely acting through a molecular mimicry mechanism that targets ZnT8 as reported for MAP and the two autoimmune diseases. METHODOLOGY: An enzyme-linked immunosorbent assay (ELISA) has been developed for the detection of antibodies against several epitopes deriving from HP proteins, which are highly homologous to the immunodominant ZnT8 peptides previously identified: ZnT8178-186 and ZnT8186-194. RESULTS: None of the HP peptides tested were significantly recognized when the humoral responses of 92 HT patients and 91 healthy volunteers were analyzed. CONCLUSIONS: These findings do not support a triggering role for HP (through ZnT8 mimicking) in HT. If a molecular mimicry phenomenon is taking place, it involves a different self-antigen. Moreover, the negative outcome of the experiments performed stresses the fact that sharing stretches of sequence homology is relevant, but not enough to trigger an antibody-mediated cross-recognition.


Subject(s)
Antibodies, Bacterial/blood , Antigens, Bacterial/immunology , Cation Transport Proteins/immunology , Hashimoto Disease/complications , Helicobacter Infections/immunology , Helicobacter pylori/immunology , Adult , Aged , Autoantibodies/immunology , Cross Reactions , Enzyme-Linked Immunosorbent Assay , Female , Humans , Male , Middle Aged , Zinc Transporter 8
4.
Viral Immunol ; 28(7): 385-90, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26083265

ABSTRACT

A role for Epstein-Barr Virus (EBV) infection in the etiology of autoimmune diseases, including rheumatoid arthritis (RA), has long been suggested. However, data about EBV burden in RA patients from Sardinian population, a genetic isolate with high prevalence of autoimmune diseases, have not yet been reported. One hundred thirty-five, Sardinian subjects (77 RA patients and 58 demographically matched healthy donors, HDs) were enrolled in a cross-sectional case-control study. EBV-DNA was quantified by quantitative real-time polymerase chain reaction in peripheral blood mononuclear cells (PBMCs). Prevalence and titers of anti-Early Antigen IgG (anti-EA-IgG) and anti-Epstein-Barr Nuclear Antigen 1 IgG (anti-EBNA-1 IgG) were determined by immunoenzimatic assay. EBV-DNA positivity was more frequent in RA PBMCs than in HD PBMCs (79.2% vs. 56.9% respectively, p=0.008). Similarly EBV relative load was increased in RA than in HD PBMCs [2.83 (6.5) vs. 0.53 (1) 2(-ΔCt) EBV-DNA, respectively, p=0.02]. Moreover, Sardinian RA patients were found to have increased prevalence of anti-EBNA-1 IgG (90% vs. only 69% of HD, p=0.006) and anti-EA IgG (37% compared with only 10.3% of HD, p=0.002). Subgroup analysis revealed that PBMCs from RA receiving Tocilizumab, an anti-interleukin-6 (IL-6) receptor monoclonal inhibitor, have significantly lower EBV viral loads in comparison to PBMCs from RA under other immunosuppressors (p=0.03). These data suggest an association between EBV infection and RA in the Sardinian population. The potential influence of IL-6 inhibition on EBV viral load in RA patients should be further explored in prospective trials.


Subject(s)
Antibodies, Viral/blood , Arthritis, Rheumatoid/etiology , DNA, Viral/blood , Epstein-Barr Virus Infections/complications , Viral Load , Aged , Case-Control Studies , Cross-Sectional Studies , Enzyme-Linked Immunosorbent Assay , Female , Humans , Italy , Male , Middle Aged , Real-Time Polymerase Chain Reaction
5.
PLoS One ; 9(9): e107802, 2014.
Article in English | MEDLINE | ID: mdl-25226393

ABSTRACT

PURPOSE: MAP3865c, a Mycobacterium avium subspecies paratuberculosis (MAP) cell membrane protein, has a relevant sequence homology with zinc transporter 8 (ZnT8), a beta-cell membrane protein involved in Zn++ transportation. Recently, antibodies recognizing MAP3865c epitopes have been shown to cross-react with ZnT8 in type 1 diabetes patients. The purpose of this study was to detect antibodies against MAP3865c peptides in patients with high-risk proliferative diabetic retinopathy and speculate on whether they may somehow be involved in the pathogenesis of this severe retinal disorder. METHODS: Blood samples were obtained from 62 type 1 and 80 type 2 diabetes patients with high-risk proliferative diabetic retinopathy and 81 healthy controls. Antibodies against 6 highly immunogenic MAP3865c peptides were detected by indirect ELISA. RESULTS: Type 1 diabetes patients had significantly higher rates of positive antibodies than controls. Conversely, no statistically significant differences were found between type 2 diabetes patients and controls. After categorization of type 1 diabetes patients into two groups, one with positive, the other with negative antibodies, we found that they had similar mean visual acuity (∼ 0.6) and identical rates of vitreous hemorrhage (28.6%). Conversely, Hashimoto's thyroiditis prevalence was 4/13 (30.7%) in the positive antibody group and 1/49 (2%) in the negative antibody group, a statistically significant difference (P = 0.016). CONCLUSIONS: This study confirmed that type 1 diabetes patients have significantly higher rates of positive antibodies against MAP/ZnT8 peptides, but failed to find a correlation between the presence of these antibodies and the severity degree of high-risk proliferative diabetic retinopathy. The significantly higher prevalence of Hashimoto's disease among type 1 diabetes patients with positive antibodies might suggest a possible common environmental trigger for these conditions.


Subject(s)
Antibodies, Bacterial/immunology , Cation Transport Proteins/immunology , Cross Reactions/immunology , Diabetic Retinopathy/immunology , Insulin-Secreting Cells/immunology , Mycobacterium avium subsp. paratuberculosis/immunology , Adolescent , Adult , Aged , Antibodies, Bacterial/blood , Case-Control Studies , Cation Transport Proteins/chemistry , Child , Child, Preschool , Diabetes Mellitus, Type 1/blood , Diabetes Mellitus, Type 1/immunology , Diabetes Mellitus, Type 1/pathology , Diabetes Mellitus, Type 2/blood , Diabetes Mellitus, Type 2/immunology , Diabetes Mellitus, Type 2/pathology , Diabetic Retinopathy/blood , Diabetic Retinopathy/pathology , Epitopes/immunology , Female , Humans , Infant , Infant, Newborn , Insulin-Secreting Cells/pathology , Male , Middle Aged , Peptides/immunology , Seroepidemiologic Studies , Young Adult , Zinc Transporter 8
6.
J Infect Dev Ctries ; 7(3): 203-7, 2013 Mar 14.
Article in English | MEDLINE | ID: mdl-23492997

ABSTRACT

INTRODUCTION: Recent findings propose that Mycobacterium avium subsp. paratuberculosis (MAP) infection could act as risk factor in favoring multiple sclerosis (MS) progression. SLC11A1 is a gene associated with mycobacterial survival in the host and it may be involved in the induction and maintenance of autoimmune disease. METHODOLOGY: In this preliminary study, 100 MS patients and 100 healthy controls (HCs) from Sardinia were enrolled. Eight single nucleotide polymorphisms (SNPs) in the SLC11A gene were searched by PCR RFLP-genotyping. IS900 specie specific PCR was undertaken to search for MAP presence. Indirect ELISA was performed to asses if MS patients displayed a stronger humoral response against MAP2694 protein compared to the HCs. RESULTS: Only rs2276631 SNP was associated with MS. MAP DNA was detected in 23 out of 100 MS patients (23%) and in 7 out of 100 HCs (7%). A strong humoral response against MAP2694 protein was detected in 36% of MS patients and only in 3% of HCs. A correlation between ELISA sero-positivity and the rs2276631 SNP was also found. CONCLUSION: Our preliminary results suggest that the Sardinian population might be prone to develop autoimmune disease due to polymorphisms in immunomodulating the SLC11A1 gene, which is important in the immune response against intracellular bacteria such as MAP.


Subject(s)
Cation Transport Proteins/genetics , Multiple Sclerosis/epidemiology , Multiple Sclerosis/genetics , Mycobacterium avium subsp. paratuberculosis/immunology , Paratuberculosis/epidemiology , Paratuberculosis/genetics , Polymorphism, Single Nucleotide , Adult , DNA Fingerprinting , Female , Genotype , Humans , Italy/epidemiology , Male , Middle Aged , Paratuberculosis/immunology , Paratuberculosis/microbiology , Polymerase Chain Reaction , Polymorphism, Restriction Fragment Length
7.
Clin Dev Immunol ; 2012: 785262, 2012.
Article in English | MEDLINE | ID: mdl-22844325

ABSTRACT

Mycobacterium avium subsp. paratuberculosis (MAP) is the etiological agent of Johne's disease in ruminants. Recent studies have linked MAP to type 1 diabetes (T1D) in the Sardinian population. The aim of this study was to investigate the prevalence of MAP infection in a T1D cohort from continental Italy compared with healthy control subjects. 247 T1D subjects and 110 healthy controls were tested for the presence of MAP. MAP DNA was detected using IS900-specific polymerase chain reaction (PCR). The presence of antibodies towards a MAP antigen, heparin binding hemoagglutinin (HBHA), was detected by ELISA. We demonstrated a higher MAP DNA prevalence in plasma samples from T1D patients and a stronger immune response towards MAP HBHA, compared with healthy control subjects. Moreover, in the recent onset patients, we observed an association between anti-MAP antibodies and HLA DQ2 (DQA1 0201/DQB1 0202). These findings taken together support the hypothesis of MAP as an environmental risk factor for the development of T1D in genetically predisposed subjects, probably involving a mechanism of molecular mimicry between MAP antigens and pancreatic islet ß-cells.


Subject(s)
Diabetes Mellitus, Type 1/complications , Diabetes Mellitus, Type 1/microbiology , Mycobacterium Infections/complications , Mycobacterium avium subsp. paratuberculosis/immunology , Antibodies, Bacterial/blood , Child , Diabetes Mellitus, Type 1/immunology , Humans , Italy , Mycobacterium Infections/microbiology , Mycobacterium avium subsp. paratuberculosis/genetics , Mycobacterium avium subsp. paratuberculosis/isolation & purification , Risk Factors
8.
Mult Scler ; 18(8): 1181-4, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22261119

ABSTRACT

Sardinia acts as an ideal setting for multiple sclerosis (MS) studies because its prevalence of MS is one of the highest worldwide. Several pathogens have been investigated amongst 119 Sardinian MS patients and 117 healthy controls to determine whether they might have a role in triggering MS in genetically predisposed individuals. Mycobacterium avium subsp. paratuberculosis (MAP) and Epstein Barr virus DNA were detected in 27.5% and 17.3%, respectively, of the MS patients. Moreover an extremely high humoral immune response against MAP recombinant protein MAP FprB (homologous to human myelin P0) was observed, whereas no significant results were found against Mycobacterium tuberculosis FprA and Helicobacter pylori HP986 protein.


Subject(s)
Epstein-Barr Virus Infections/virology , Herpesvirus 4, Human/isolation & purification , Multiple Sclerosis/microbiology , Multiple Sclerosis/virology , Mycobacterium avium subsp. paratuberculosis/isolation & purification , Paratuberculosis/microbiology , Adult , Antibodies, Bacterial/blood , Case-Control Studies , Chi-Square Distribution , DNA, Bacterial/isolation & purification , DNA, Viral/isolation & purification , Enzyme-Linked Immunosorbent Assay , Epstein-Barr Virus Infections/diagnosis , Epstein-Barr Virus Infections/epidemiology , Female , Genetic Predisposition to Disease , Herpesvirus 4, Human/genetics , Herpesvirus 4, Human/pathogenicity , Humans , Immunity, Humoral , Italy/epidemiology , Logistic Models , Male , Middle Aged , Multiple Sclerosis/epidemiology , Multiple Sclerosis/genetics , Mycobacterium avium subsp. paratuberculosis/genetics , Mycobacterium avium subsp. paratuberculosis/immunology , Mycobacterium avium subsp. paratuberculosis/pathogenicity , Odds Ratio , Paratuberculosis/diagnosis , Paratuberculosis/epidemiology , Paratuberculosis/immunology , Polymerase Chain Reaction , Prevalence , Risk Assessment , Risk Factors
9.
PLoS One ; 6(10): e26931, 2011.
Article in English | MEDLINE | ID: mdl-22046415

ABSTRACT

The environmental factors at play in the pathogenesis of type 1 diabetes (T1D) remain enigmatic. Mycobacterium avium subspecies paratuberculosis (MAP) is transmitted from dairy herds to humans through food contamination. MAP causes an asymptomatic infection that is highly prevalent in Sardinian T1D patients compared with type 2 diabetes (T2D) and healthy controls. Moreover, MAP elicits humoral responses against several mycobacterial proteins. We asked whether antibodies (Abs) against one of these proteins, namely MAP3865c, which displays a sequence homology with the ß-cell protein zinc transporter 8 (ZnT8) could be cross-reactive with ZnT8 epitopes. To this end, Ab responses against MAP3865c were analyzed in Sardinian T1D, T2D and healthy subjects using an enzymatic immunoassay. Abs against MAP3865c recognized two immunodominant transmembrane epitopes in 52-65% of T1D patients, but only in 5-7% of T2D and 3-5% of healthy controls. There was a linear correlation between titers of anti-MAP3865c and anti-ZnT8 Abs targeting these two homologous epitopes, and pre-incubation of sera with ZnT8 epitope peptides blocked binding to the corresponding MAP3865c peptides. These results demonstrate that Abs recognizing MAP3865c epitopes cross-react with ZnT8, possibly underlying a molecular mimicry mechanism, which may precipitate T1D in MAP-infected individuals.


Subject(s)
Cation Transport Proteins/immunology , Cross Reactions/immunology , Diabetes Mellitus, Type 1/immunology , Insulin-Secreting Cells/immunology , Mycobacterium avium subsp. paratuberculosis/immunology , Adolescent , Adult , Antigens, Bacterial/immunology , Child , Diabetes Mellitus, Type 1/etiology , Epitopes/immunology , Humans , Italy , Paratuberculosis/complications , Paratuberculosis/immunology , Young Adult , Zinc Transporter 8
10.
Clin Immunol ; 141(1): 49-57, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21664191

ABSTRACT

Mycobacterium avium subsp. paratuberculosis (Map) is the causative agent of Johne's disease, a chronic inflammation of ruminants' intestine. Recent studies have linked Map to type I Diabetes mellitus (T1DM). We searched the presence of antibodies against two specific proteins of Map (MptD and MAP3738c) in sera of patients affected by T1DM and type II Diabetes mellitus (T2DM). MptD protein (MAP3733c) has been recognized as a Map virulent factor whereas MAP3738c has not yet been studied. Both proteins are encoded by genes belonging to a Map specific pathogenicity island. Forty three T1DM patients' sera, 56 T2DM patients' sera and 48 healthy subjects' sera were screened by ELISA to evaluate the immunoresponse against MptD or MAP3738c recombinant proteins. Results showed a positive response to both proteins in T1DM patients whereas no difference with controls was found for T2DM patients. Results suggest a potential relation between T1DM and the bacterial infection.


Subject(s)
Diabetes Complications/immunology , Diabetes Complications/microbiology , Diabetes Mellitus, Type 1/complications , Diabetes Mellitus, Type 1/microbiology , Mycobacterium avium subsp. paratuberculosis/immunology , Paratuberculosis/complications , Paratuberculosis/immunology , Adult , Aged , Antibodies, Bacterial/blood , Antigens, Bacterial/genetics , Bacterial Proteins/genetics , Bacterial Proteins/immunology , Base Sequence , Case-Control Studies , DNA, Bacterial/genetics , Diabetes Mellitus, Type 1/immunology , Diabetes Mellitus, Type 2/complications , Diabetes Mellitus, Type 2/immunology , Diabetes Mellitus, Type 2/microbiology , Enzyme-Linked Immunosorbent Assay , Female , Genes, Bacterial , Humans , Male , Middle Aged , Mycobacterium avium subsp. paratuberculosis/genetics , Paratuberculosis/microbiology , Recombinant Proteins/genetics , Recombinant Proteins/immunology , Young Adult
11.
PLoS One ; 6(4): e18482, 2011 Apr 13.
Article in English | MEDLINE | ID: mdl-21533236

ABSTRACT

Mycobacterium avium subsp. paratuberculosis (MAP) infection is highly spread in the ruminant herds of Sardinia, in the Western Mediterranean. The objective of this study was to investigate prevalence of MAP infection in association with Multiple Sclerosis (MS) using clinical specimen from patients and controls. We analyzed samples for the presence of MAP specific DNA and to demonstrate humoral response to a MAP protein (MAP2694), a predicted homologue of the T-cell receptor gamma-chain/complement component 1 of the host. We found presence of MAP DNA in 42% of the MS patients and an extremely significant humoral immune response revealed by the MS patients against the MAP protein. In our opinion, this is the first report that significantly associates MAP infection with MS. Further studies will be required to confirm if MAP could be one of the triggers of MS, according to the molecular mimicry theory, in susceptible (and genetically at risk) individuals.


Subject(s)
Multiple Sclerosis/microbiology , Mycobacterium avium subsp. paratuberculosis/isolation & purification , Paratuberculosis/complications , Adult , Amino Acid Sequence , Bacterial Proteins/chemistry , Cloning, Molecular , DNA, Bacterial/isolation & purification , Enzyme-Linked Immunosorbent Assay , Female , Humans , Italy/epidemiology , Male , Middle Aged , Molecular Sequence Data , Multiple Sclerosis/complications , Mycobacterium avium subsp. paratuberculosis/genetics , Paratuberculosis/epidemiology , Polymerase Chain Reaction , Sequence Homology, Amino Acid
13.
PLoS One ; 4(9): e7109, 2009 Sep 21.
Article in English | MEDLINE | ID: mdl-19768110

ABSTRACT

BACKGROUND: The etiology of type 1 diabetes mellitus (T1DM) is still unknown; numerous studies are performed to unravel the environmental factors involved in triggering the disease. SLC11A1 is a membrane transporter that is expressed in late endosomes of antigen presenting cells involved in the immunopathogenic events leading to T1DM. Mycobacterium avium subsp. paratuberculosis (MAP) has been reported to be a possible trigger in the development of T1DM. METHODOLOGY/PRINCIPAL FINDINGS: Fifty nine T1DM patients and 79 healthy controls were genotyped for 9 polymorphisms of SLC11A1 gene, and screened for the presence of MAP by PCR. Differences in genotype frequency were evaluated for both T1DM patients and controls. We found a polymorphism in the SLC11A1 gene (274C/T) associated to type 1 diabetic patients and not to controls. The presence of MAP DNA was also significantly associated with T1DM patients and not with controls. CONCLUSIONS/SIGNIFICANCE: The 274C/T SCL11A1 polymorphism was found to be associated with T1DM as well as the presence of MAP DNA in blood. Since MAP persists within macrophages and it is also processed by dendritic cells, further studies are necessary to evaluate if mutant forms of SLC11A1 alter the processing or presentation of MAP antigens triggering thereby an autoimmune response in T1DM patients.


Subject(s)
Autoimmune Diseases/genetics , Autoimmune Diseases/microbiology , Cation Transport Proteins/genetics , Diabetes Mellitus, Type 1/genetics , Diabetes Mellitus, Type 1/microbiology , Infections/genetics , Mycobacterium avium subsp. paratuberculosis/metabolism , Polymorphism, Genetic , Adolescent , Adult , Aged , Aged, 80 and over , Autoimmune Diseases/complications , Case-Control Studies , Dendritic Cells/metabolism , Diabetes Complications/genetics , Diabetes Complications/microbiology , Female , Humans , Macrophages/metabolism , Male , Middle Aged
14.
PLoS One ; 4(2): e4386, 2009.
Article in English | MEDLINE | ID: mdl-19204799

ABSTRACT

BACKGROUND: Mycobacterium avium subspecies paratuberculosis (MAP) is a versatile pathogen with a broad host range. Its association with type-1 diabetes mellitus (T1DM) has been recently proposed. Rapid identification of infectious agents such as MAP in diabetic patients at the level of clinics might be helpful in deciphering the role of chronic bacterial infection in the development of autoimmune diseases such as T1DM. METHODOLOGY/PRINCIPAL FINDINGS: We describe use of an ELISA method to identify live circulating MAP through the detection of a cell envelope protein, MptD by a specific M13 phage--fMptD. We also used another ELISA format to detect immune response to MptD peptide. Both the methods were tested with blood plasma obtained from T1DM, type-2 diabetes (T2DM) patients and non-diabetic controls. Our results demonstrate MptD and fMptD ELISA assays to be accurate and sensitive to detect MAP bacilli in a large fraction (47.3%) of T1DM patients as compared to non-diabetic controls (12.6%) and those with confirmed T2DM (7.7%). Comparative analysis of ELISA assays performed here with 3 other MAP antigen preparations, namely HbHA, Gsd and whole cell MAP lysates confirmed comparable sensitivity of the MptD peptide and the fMptD based ELISA assays. Moreover, we were successful in demonstrating positive bacterial culture in two of the clinical specimen derived from T1DM patients. CONCLUSIONS AND SIGNIFICANCE: The MptD peptide/fMptD based ELISA or similar tests could be suggested as rapid and specific field level diagnostic tests for the identification of MAP in diabetic patients and for finding the explanations towards the occurrence of type-1 or type-2 diabetes in the light of an active infectious trigger.


Subject(s)
Diabetes Mellitus, Type 1/microbiology , Diabetes Mellitus, Type 2/microbiology , Immunoassay/methods , Mycobacterium avium subsp. paratuberculosis/immunology , Antibodies, Bacterial/immunology , Antigens, Bacterial/immunology , Case-Control Studies , Cell Extracts/immunology , Diabetes Mellitus, Type 1/blood , Diabetes Mellitus, Type 1/immunology , Diabetes Mellitus, Type 2/immunology , Humans , Mycobacterium avium subsp. paratuberculosis/isolation & purification , Peptides/immunology , Recombinant Proteins/immunology
15.
Can J Neurol Sci ; 35(4): 491-4, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18973068

ABSTRACT

BACKGROUND: Multiple sclerosis (MS) is believed to be an autoimmune disease occurring in genetically predisposed individuals after an appropriate environmental exposure such as viral infections. Recent studies suggest a significant association between MS and the functional 5'-(GT)n polymorphism in the promoter region of the NRAMP1 gene. In the present study we aimed to evaluate the contribution of the allelic variation in the NRAMPI promoter to MS susceptibility and to study the role of viral infection in relation to specific NRAMP1 genotypes, in a Sardinian cohort. METHODS: Sixty MS patients and 66 healthy individuals were genotyped, and screened for the presence of Epstein-bar virus (EBV) and JC virus (JCV) sequences. RESULTS: Consistent with previous autoimmune disease studies, allele 3 at the functional 5'(GT)n promoter region repeat polymorphism, was significantly overrepresented among MS patients when compared to controls (p=0.02). The EBV and JCV sequences were detected in 8/60 (13.33%) and in 4/60 (6.66%) of MS patients respectively and in 5/66 (7.57%) and in 0/66 of controls. CONCLUSION: The allelic variation in the NRAMP1 promoter may contribute to MS susceptibility in the Sardinian population. The viral sequences were not confined to a specific NRAMP1 genotype.


Subject(s)
Cation Transport Proteins/genetics , Multiple Sclerosis/genetics , Polymorphism, Genetic , Cation Transport Proteins/metabolism , Gene Frequency , Genetic Predisposition to Disease , Genotype , Herpesvirus 4, Human/genetics , Humans , Italy , JC Virus/genetics , Multiple Sclerosis/virology , Promoter Regions, Genetic
16.
Ann Clin Microbiol Antimicrob ; 7: 9, 2008 Apr 22.
Article in English | MEDLINE | ID: mdl-18430197

ABSTRACT

BACKGROUND: The role of pathogenic mycobacteria in diabetes has been a focus of speculation since a decade without any meaningful insights into the mechanism of diabetes causation vis a vis mycobacterial factors. Two of our studies based on PCR identification of mycobacterial DNA and detection of antibodies specific to the recombinant antigens and whole cell lysates of the Mycobacterium avium subsp. paratuberculosis (MAP) shown a clear association of MAP with the presence of type 1 diabetes mellitus (T1DM). METHODS: In this study, we sought to investigate if or not type 2 diabetes (T2DM) patients harbour humoral responses to MAP. Using three different MAP antigen preparations, humoral antibody profiles were estimated for 57 T2DM patients and 57 healthy controls. Statistical analysis was performed with the Chi-square test with Yates' corrections. RESULTS: We observed insignificant levels of humoral antibodies against recombinant heparin binding haemagglutinin (HbHA), glycosyl transferase (Gsd) and MAP whole cell lysate in the blood of subjects with T2DM as compared to healthy controls. CONCLUSION: We found no obvious association of MAP with the incidence of T2DM in Sardinian patients.


Subject(s)
Diabetes Mellitus, Type 2/microbiology , Mycobacterium avium subsp. paratuberculosis/immunology , Antibodies, Bacterial/blood , Antigens, Bacterial/blood , Case-Control Studies , Diabetes Mellitus, Type 2/blood , Diabetes Mellitus, Type 2/immunology , Enzyme-Linked Immunosorbent Assay , Humans , Italy , Lectins/blood , Mycobacterium avium subsp. paratuberculosis/isolation & purification , Paratuberculosis/complications
18.
World J Gastroenterol ; 13(43): 5731-5, 2007 Nov 21.
Article in English | MEDLINE | ID: mdl-17963299

ABSTRACT

AIM: To establish the role of enteric glial cells during infection with Mycobacterium avium subspecies paratuberculosis (MAP) in Crohn's disease. METHODS: In order to establish the role of enteric glial cells during infection with M. avium subspecies paratuberculosis (MAP) in Crohn's disease, Map adhesion experiments on enteric glial cells were performed as well as expression analysis of Map sigma factors during infection. RESULTS: In this study, for the first time, we found a high affinity of MAP to enteric glial cells and we analyzed the expression of MAP sigma factors under different conditions of growth. CONCLUSION: The fact that Map showed a high affinity to the glial cells raises concerns about the complicated etiology of the Crohn's disease. Elucidation of the mechanisms whereby inflammation alters enteric neural control of gut functions may lead to novel treatments for Crohn's disease.


Subject(s)
Enteric Nervous System/pathology , Mycobacterium avium subsp. paratuberculosis/pathogenicity , Neuroglia/virology , Cell Line , Crohn Disease/etiology , Crohn Disease/pathology , Crohn Disease/virology , Humans , Mycobacterium avium subsp. paratuberculosis/growth & development , Neuroglia/pathology , Paratuberculosis/metabolism , Paratuberculosis/pathology , Sigma Factor/metabolism
19.
Infect Genet Evol ; 7(4): 424-32, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17292677

ABSTRACT

Mycobacterium avium subsp. paratuberculosis (MAP) is the etiological agent of Johne's disease (JD), a chronic gastroenteritis of ruminants and other animals, including primates. Many evidences suggested association of MAP to Crohn's disease, a chronic granulomatous gastrointestinal disease of humans with strong similarities with JD. The present study attempts to evaluate global gene regulation in MAP, which has not been addressed previously, despite the availability of MAP genome sequence. For this purpose, we investigated: (i) the presence of sigma factors and their relationship to sigma factors of other mycobacteria (M. avium subsp.avium, M. tuberculosis, M. bovis, M. leprae and M. smegmatis), and (ii) their expression during different growth conditions and in vitro infection of intestinal epithelial Caco2 cells. MAP genome contains 19 putative sigma factor, but only 12 belong to gene families common to other mycobacteria. Gene expression was evaluated with Real-Time PCR during growth in 7H9 medium and mycobactin J, in 7H9 medium plus mycobactin J and lisozyme, and during infection of Caco2 cells: very different expression patterns were observed and, on the whole, only 7 sigma factors were found to be expressed. sigJ was upregulated during the infection of Caco2 cells. Even if only few sigma factors were expressed in the three conditions tested, the overall high numbers of MAP sigma factors suggests a noteworthy flexibility of this pathogen. Thus, this first report on expression of MAP sigma factors opens the way to an extensive characterization of global gene regulation, as a key to understand strategies of survival and mechanisms of infections used by this organism.


Subject(s)
Genome, Bacterial/genetics , Mycobacterium avium subsp. paratuberculosis/genetics , Mycobacterium avium/genetics , Sigma Factor/genetics , Sigma Factor/metabolism , Transcription, Genetic , Caco-2 Cells , Epithelial Cells/drug effects , Epithelial Cells/microbiology , Gene Expression Regulation, Bacterial/drug effects , Humans , Intestines/cytology , Intestines/drug effects , Intestines/microbiology , Muramidase/metabolism , Mycobacterium avium/drug effects , Mycobacterium avium/growth & development , Mycobacterium avium subsp. paratuberculosis/drug effects , Mycobacterium avium subsp. paratuberculosis/growth & development , Oxazoles/pharmacology , Phylogeny , Transcription, Genetic/drug effects
20.
World J Gastroenterol ; 12(44): 7161-4, 2006 Nov 28.
Article in English | MEDLINE | ID: mdl-17131479

ABSTRACT

AIM: To study the association between Crohn's disease (CD), Mycobacterium avium subspecies paratuberculosis (MAP), and genetic factors by examining the role of natural resistance-associated macrophage protein 1 (NRAMP1) gene polymorphisms (now SLC11A1) in Sardinian patients with CD and controls. METHODS: Thirty-seven CD patients and 34 controls with no inflammatory bowel disease (IBD) were recruited at the University of Sassari after giving written consent. Six SCL11A1 polymorphisms previously reported to be the most significantly associated with IBD were searched. M. paratuberculosis was identified by IS900 PCR and sequencing. Logistic regression was used to calculate odds ratios (OR) for the associations among CD, presence of MAP, and 6 loci described above. RESULTS: For the first time, a strong association was observed between polymorphisms at NRAMP1 locus 823C/T and CD. While CD was strongly associated with both NRAMP1 and MAP, NRAMP1 polymorphisms and MAP themselves were not correlated. CONCLUSION: Combined with previous work on the NOD2/CARD15 gene, it is clear that the interplay of genetic, infectious, and immunologic factors in the etiology of CD is complex.


Subject(s)
Cation Transport Proteins/genetics , Crohn Disease/genetics , Crohn Disease/microbiology , Mycobacterium avium , Case-Control Studies , Humans , Italy , Polymorphism, Genetic
SELECTION OF CITATIONS
SEARCH DETAIL
...